They found that cisplatin could induce MDA-MB-231 cell pyroptosis via upregulating the lnc RNA MEG3 and activating the NLRP3/caspase-1/GSDMD pathway, which would accelerate the inflammatory cytokines (IL-18 or IL-1β) release and effectively treat breast cancer. Here, GSDMD is linked to breast carcinoma.